Celestia Diagnostics
About Celestia Diagnostics
Celestia Diagnostics is developing a blood test for the accurate diagnosis of Long COVID and other infection-associated chronic conditions, addressing the current lack of reliable testing methods. This diagnostic tool aims to enhance the treatment and management of these conditions by providing measurable insights into patient health.
```xml <problem> Millions of individuals suffer from Long COVID, a chronic condition triggered by COVID-19. The absence of reliable diagnostic tests for Long COVID hinders accurate diagnosis, effective treatment, and further research into the condition. </problem> <solution> Celestia Diagnostics is developing a blood test designed for the accurate diagnosis of Long COVID and other infection-associated chronic conditions. This diagnostic tool aims to bridge the gap between scientific research and clinical application, providing measurable insights into patient health. By offering a reliable diagnostic method, Celestia Diagnostics seeks to improve the treatment, management, and understanding of Long COVID. </solution> <features> - Blood test for the diagnosis of Long COVID - Diagnostic tool for other infection-associated chronic conditions </features> <target_audience> The primary audience includes medical professionals, researchers, and individuals seeking accurate diagnoses for Long COVID and related conditions. </target_audience> ```
What does Celestia Diagnostics do?
Celestia Diagnostics is developing a blood test for the accurate diagnosis of Long COVID and other infection-associated chronic conditions, addressing the current lack of reliable testing methods. This diagnostic tool aims to enhance the treatment and management of these conditions by providing measurable insights into patient health.
Where is Celestia Diagnostics located?
Celestia Diagnostics is based in Fort Worth, United States.
When was Celestia Diagnostics founded?
Celestia Diagnostics was founded in 2022.
- Location
- Fort Worth, United States
- Founded
- 2022
- Employees
- 3 employees
- Major Investors
- Southern Research